background image

Paid Clinical Trials Washington, D.C.

Discover 750 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)

for
HIV Pre-exposure Prophylaxis
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: Gilead Sciences

Sex: All

Age: 16+

Code: NCT07047716

Phase3, Recruiting
Active & Responsive

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

for
Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer,
Location: Washington D.C. DC, York PA, Morristown NJ,
Sponsor: VM Oncology, LLC

Sex: All

Age: 18 - 70+

Code: NCT03556228

Phase1, Phase2, Recruiting
Active & Responsive

Controlled Human Infection Study of Orally Administered Trichuris Trichiura Eggs in Naïve Adults

for
Whipworm, Trichuriasis, Controlled Human Infection
Location: Washington D.C. DC, Bethesda MD
Sponsor: George Washington University

Sex: All

Age: 18 - 45

Code: NCT05706116

Phase1, Recruiting
Active & Responsive

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

for
Generalized Myasthenia Gravis
Location: Washington D.C. DC, Falls Church VA, Chapel Hill NC,
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Sex: All

Age: 18+

Code: NCT06463587

Phase3, Recruiting
Active & Responsive

Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)

for
Breast Cancer Stage I, Breast Cancer Stage II,
Location: Washington D.C. DC
Sponsor: George Washington University

Sex: All

Age: 21+

Code: NCT06806930

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

for
Prostate Cancer, Prostatic Neoplasms
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: Merck Sharp & Dohme LLC

Sex: Male

Age: 18+

Code: NCT06925737

Phase3, Recruiting
Active & Responsive

StrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms

for
Vulvar Lichen Sclerosus
Location: Washington DC, Tampa FL, New York NY
Sponsor: Andrew T. Goldstein, MD

Sex: Female

Age: 18+

Code: NCT06662942

Phase1, Recruiting
Active & Responsive

Topical Ketotifen 0.25% for Secondary Vestibulodynia

for
Provoked Vestibulodynia, Secondary Provoked Vestibulodynia,
Location: Washington D.C. DC, Tampa FL, New York NY
Sponsor: Center for Vulvovaginal Disorders

Sex: Female

Age: 18+

Code: NCT07257029

Phase2, Recruiting
Active & ResponsiveNew

A Phase 1 Randomized, Observer-blind, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health

for
Marburg Virus Disease
Location: Washington D.C. DC, Lenexa KS
Sponsor: International AIDS Vaccine Initiative

Sex: All

Age: 18 - 50

Code: NCT07425821

Phase1, Recruiting
Active & Responsive

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

for
Mesial Temporal Lobe Epilepsy
Location: Washington D.C. DC, Philadelphia PA, New York NY,
Sponsor: Neurona Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT05135091

Phase3, Recruiting